long half-life and large variability [Regulatives / Guidelines]

posted by dshah  – India/United Kingdom, 2020-08-10 08:18 (953 d 00:34 ago) – Posting: # 21846
Views: 2,039

Hi All!

I believe there are few MR drug with high variability and still USFDA recommends partial or fully replicate design. Mesalamine PSG or
Mesalamine PSG for 800 mg strength
Considering the Mechanism of Action, PK variability, non-Linearity- the study and formultion could indeed be challenging.

Regards,
Dshah

Complete thread:

UA Flag
Activity
 Admin contact
22,546 posts in 4,721 threads, 1,608 registered users;
21 visitors (0 registered, 21 guests [including 7 identified bots]).
Forum time: 07:53 CET (Europe/Vienna)

Science is the great antidote to the poison
of enthusiasm and superstition.    Adam Smith

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5